524632 logo

Shukra Pharmaceuticals Limited Stock Price

BSE:524632 Community·₹14.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

524632 Share Price Performance

₹31.89
11.31 (54.96%)
₹31.89
11.31 (54.96%)
Price ₹31.89

524632 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Outstanding track record with excellent balance sheet.

1 Risk
1 Reward

Shukra Pharmaceuticals Limited Key Details

₹645.7m

Revenue

₹118.5m

Cost of Revenue

₹527.2m

Gross Profit

₹235.6m

Other Expenses

₹291.6m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
0.67
81.64%
45.16%
5.7%
View Full Analysis

About 524632

Founded
1993
Employees
115
CEO
Dakshesh Shah
WebsiteView website
www.shukrapharmaceuticals.com

Shukra Pharmaceuticals Limited manufactures and markets pharmaceutical products in India and internationally. Its product portfolio includes macrolides, quinolones, anti-bacterial, anti-fungal, anti-malarial, anti-viral, anti-protozoal, anti-anthelmintic, sedative and tranquillizer, anti-depressant, anti-manic, anti-emetic, anti-ulcer, beta blockers, diuretics, analgesic, muscle relaxants, anti-tuberculosis, vitamin products, anti-allergics, corticosteroids, hyper and hypoglycemic, and other products, as well as antibiotics, such as penicillin and cephalosporin. The company was formerly known as Relish Pharmaceuticals Limited and changed its name to Shukra Pharmaceuticals Limited in August 2016. Shukra Pharmaceuticals Limited was incorporated in 1993 and is based in Ahmedabad, India.

Recent 524632 News & Updates

Recent updates

No updates